El Achhab Youness, Nejjari Chakib, Chikri Mohamed, Lyoussi Badiaa
Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy, Fez, Morocco.
Diabetes Res Clin Pract. 2008 May;80(2):171-84. doi: 10.1016/j.diabres.2007.12.020. Epub 2008 Feb 14.
This paper provides a systematic review on health-related quality of life (HRQoL) measures in diabetic patients. For each included study, a description of the measure and its psychometric findings is provided. To evaluate these measures, a databases search (Medline, Scopus and Proqolid) was undertaken to identify relevant publications. Instruments were assessed according to predefined inclusion and exclusion criteria. Sixteen instruments met the inclusion criteria among 1049 references produced: appraisal of diabetes scale (ADS), audit of diabetes-dependent quality of life (ADDQoL), diabetes-39 (D-39), diabetes care profile (DCP), diabetes distress scale (DDS), diabetes health profile (DHP-1, DHP-18), diabetes impact measurement scales (DIMS), diabetes quality of life measure (DQOL), diabetes quality of life clinical trial questionnaire-revised (DQLCTQ-R), diabetes-specific quality of life scale (DSQOLS), elderly diabetes burden scale (EDBS), insulin delivery system rating questionnaire (IDSRQ), quality of life with diabetes questionnaire (LQD), problem areas in diabetes scale (PAID), questionnaire on stress in diabetic patients-revised (QSD-R) and well-being enquiry for diabetics (WED). All those instruments have been developed in northern countries. The shortest instrument (ADS) has seven items and the longest (IDSRQ) has 67 items. ADDQoL was widely translated followed by DHP and PAID. Only authors of ADS and DIMS have not involved patients in the construction of instruments. The authors of instruments: ADS, ADDQoL, DHP, D-39, and PAID reported the item-total correlation which is ranged from 0.28 to 0.84. The ADS, DQOL, EDBS, IDSRQ, LQD, PAID, QSD-R, and WED have been assessed for test-retest reliability which varies between 0.27 and 0.99. The DQLCTQ-R, DQOL and IDSRQ were not subjected to factor analysis. Responsiveness was assessed in PAID with effect sizes and ranged from 0.32 to 0.65 for interventions. Four domains were responsive to clinical change in metabolic control in DQLCTQ-R. The other instruments were not been formally assessed for responsiveness. This review found evidence that the instruments: ADDQoL, D-39, DDS, DHP1/18, DSQOLS, EDBS and QSD-R had adequate psychometric properties. For future research, responsiveness should be a priority and further study is also required to examine the effect of ethnicity and to determine the validity of these scales in developing countries.
本文对糖尿病患者健康相关生活质量（HRQoL）测量方法进行了系统综述。对于每项纳入研究，均提供了测量方法及其心理测量学结果的描述。为评估这些测量方法，进行了数据库检索（Medline、Scopus和Proqolid）以识别相关出版物。根据预定义的纳入和排除标准对工具进行评估。在产生的1049篇参考文献中，有16种工具符合纳入标准：糖尿病评估量表（ADS）、糖尿病依赖生活质量审计量表（ADDQoL）、糖尿病-39量表（D-39）、糖尿病护理概况量表（DCP）、糖尿病困扰量表（DDS）、糖尿病健康概况量表（DHP-1、DHP-18）、糖尿病影响测量量表（DIMS）、糖尿病生活质量测量量表（DQOL）、糖尿病生活质量临床试验问卷修订版（DQLCTQ-R）、糖尿病特异性生活质量量表（DSQOLS）、老年糖尿病负担量表（EDBS）、胰岛素输送系统评分问卷（IDSRQ）、糖尿病生活质量问卷（LQD）、糖尿病问题领域量表（PAID）、糖尿病患者压力问卷修订版（QSD-R）和糖尿病患者幸福感调查问卷（WED）。所有这些工具均在北方国家开发。最短的工具（ADS）有7个条目，最长的（IDSRQ）有67个条目。ADDQoL被广泛翻译，其次是DHP和PAID。只有ADS和DIMS的作者在工具构建过程中未让患者参与。ADS、ADDQoL、DHP、D-39和PAID的作者报告了项目与总分的相关性，范围为0.28至0.84。ADS、DQOL、EDBS、IDSRQ、LQD、PAID、QSD-R和WED已评估了重测信度，其范围在0.27至0.99之间。DQLCTQ-R、DQOL和IDSRQ未进行因子分析。PAID中评估了反应度，干预措施的效应大小范围为0.32至0.65。DQLCTQ-R中的四个领域对代谢控制的临床变化有反应。其他工具未正式评估反应度。本综述发现有证据表明ADDQoL、D-39、DDS、DHP1/18、DSQOLS、EDBS和QSD-R这些工具具有足够的心理测量学特性。对于未来的研究，反应度应作为优先事项且还需要进一步研究以检查种族的影响并确定这些量表在发展中国家的有效性。
